Long-term trial supports CD19-targeted CAR T cells for relapsed/refractory CLL
2 विचारों
• 07/14/23
0
0
एम्बेड
administrator
ग्राहकों
In this episode, Mark Geyer and colleagues demonstrate that second-generation CD19-targeted CAR T cell therapy following conditioning chemotherapy is tolerated in patients with relapsed/refractory CLL and can result in complete remission in a subset of patients…
और दिखाओ
फेसबुक टिप्पणियाँ
SORT BY-
सबसे ऊपर की टिप्पणी
-
नवीनतम टिप्पणियां